Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 50.77M P/E - EPS this Y - Ern Qtrly Grth -
Income -10.31M Forward P/E -1.70 EPS next Y -2.10% 50D Avg Chg 45.00%
Sales 3.73M PEG - EPS past 5Y - 200D Avg Chg 102.00%
Dividend N/A Price/Book 3.19 EPS next 5Y - 52W High Chg -40.00%
Recommedations 1.50 Quick Ratio 5.22 Shares Outstanding 8.92M 52W Low Chg 761.00%
Insider Own 12.20% ROA -40.87% Shares Float 6.76M Beta 1.55
Inst Own 22.62% ROE -71.74% Shares Shorted/Prior 64.76K/81.05K Price 5.77
Gross Margin -156.82% Profit Margin -278.22% Avg. Volume 861,779 Target Price 11.75
Oper. Margin -197.40% Earnings Date Nov 7 Volume 217,337 Change 4.72%
About Marker Therapeutics, Inc.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Marker Therapeutics, Inc. News
11/17/24 Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
11/14/24 Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/23/24 US Penny Stocks To Consider In October 2024
10/22/24 Marker Therapeutics price target raised to $19 from $11 at Ladenburg
09/26/24 AML cell therapy trials to watch in 2024 targeting GvHD
08/28/24 Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
08/14/24 Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
08/12/24 Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma
07/18/24 Marker Therapeutics (NASDAQ:MRKR) shareholders are up 20% this past week, but still in the red over the last five years
05/15/24 Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
04/08/24 Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
03/25/24 Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
03/22/24 Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
01/22/24 Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601
01/08/24 Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
01/08/24 Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
11:00 AM Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”
12/11/23 Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse
MRKR Chatroom

User Image BioRich Posted - 1 day ago

$MRKR have loved this one through thick and thin. Miss teaming them with their buddy $JNCE (since bought out). That's how old school I am on this one. Time to accumulate before movement. This will creep up over time. Solid buy and hold as we eye the finish line. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too...that's how we find hidden gems and make money. Let's make some money! Cheers!

User Image RamirezESQ Posted - 2 days ago

$MRKR very promising stock, but given the stage and timing of clinical outcomes, I think we are still a ways away from explosive movement. Great time to accumulate, but the risk of dilution still remains.

User Image YesOneHundredPercent Posted - 3 days ago

$MRKR by the time you hear about it, it will be too late.

User Image Geert07 Posted - 6 days ago

$MRKR Offering to be expected soon. Unbelievable how much time has been wasted on the AML and pancreatic trials, where they should have focussed on lymphoma from the start. That one had by far the most promising data.

User Image YesOneHundredPercent Posted - 6 days ago

$MRKR oh sheet!

User Image GoIrish1776 Posted - 6 days ago

$MRKR https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2024-financial-results

User Image RallyRaider Posted - 6 days ago

$MRKR maybe follow up on funding?

User Image itsMeRich Posted - 1 week ago

$MRKR anyone else sick of the games that traders are playing with this? I just hope it rockets while they are out, or short it.

User Image rubraquercus Posted - 1 week ago

$MRKR if the future is as bright as some not so bright permabulls around here think then just wait and place much safer bets after the news drops. Look at IOVA and how long that approved drug has taken to grow. I am a long suffering long here but only bet beer money amounts as I wait, and wait, and wait.

User Image stonks_2021 Posted - 1 week ago

$MRKR just accumulate and wait. This low float will explode when the news drops. I believe in the end this is a superior product.

User Image itsMeRich Posted - 1 week ago

$MRKR this freaking stock🙄

User Image RallyRaider Posted - 2 weeks ago

$MRKR clarification on the 10q and follow up on funding?

User Image KingNeptune Posted - 10/28/24

$GERN beautiful. Different sectors but always think $GERN and $CRMD track each other in their stage of clinical-to-production. Similar to how I saw $MRKR and $JNCE track each other in the past.

User Image Keyice Posted - 10/25/24

@Diefreeandsell @ProjectOracle I just don't want it to turn into another $MRKR, but this has some approval. What ever happened with Europe approval, or are they gonna play the douche cigarette smoking French forever on drug approval?

User Image RallyRaider Posted - 10/25/24

$MRKR remember only 6mn in the float now off the trend

User Image MRKR2025 Posted - 10/23/24

$MRKR MRKR stock price giveth and then taketh away. Very confusing, thought we might be getting some good data news, now I just don't know. I guess we just keep waiting.

User Image PenkeTrading Posted - 10/23/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Marker Therapeutics Inc. Is that bullish or bearish? $MRKR #Marker #RsiOverbought #NASDAQ

User Image KingNeptune Posted - 10/22/24

$MRKR love this. $MRKR long and nice to see it starting to do something.

User Image Keyice Posted - 10/22/24

$MRKR so are results finally coming? Its about a month overdue, but the volume is slowly starting to build. They are due results in the 3rd quarter but still nothing. But this jumped end of last week and again today. Don't see any insider buys so I am a little leary. If I can get 5.75 I'll dump my 31k shares cause its time to move on if this isn't gonna become a profitable business for another 5 years.

User Image itsMeRich Posted - 10/22/24

$MRKR #curecancer

User Image itsMeRich Posted - 10/22/24

$MRKR when’s the news?

User Image YesOneHundredPercent Posted - 10/22/24

$MRKR

User Image itsMeRich Posted - 10/22/24

$MRKR it sure would be nice to see some confirmation volume

User Image itsMeRich Posted - 10/22/24

$MRKR where are all my old- timer, MRKR friends…anyone still holding?

User Image Stocks4thought Posted - 10/22/24

$MRKR Interesting way to back out of the garage- bid ask action- to move her up!@#$RT

User Image stonks_2021 Posted - 10/22/24

$MRKR set my sell order to 30

User Image RallyRaider Posted - 10/22/24

$MRKR testing the depth of the water...

User Image Geert07 Posted - 10/22/24

$MRKR Up 10% on 17k shares.

User Image itsMeRich Posted - 10/22/24

$MRKR up 10% again….. someone is trying to buy shares…. Apparently none available

User Image RallyRaider Posted - 10/22/24

$MRKR super action.... now the dollar moves$$$

Analyst Ratings
Ladenburg Thalmann Buy Apr 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Eansor Norman David Director Director Mar 16 Buy 17.5 14,285 249,988 16,713 06/08/23